Building on Tesamorelins established clinical evidence base in fat metabolism and CJC-1295s documented effects on lipolytic parameters, this triple-peptide formulation enables investigators to study GH-driven hormone-sensitive lipase activation, adipokine regulation, and visceral fat depot dynamics across a spectrum of metabolic research models including diet-induced obesity, aging-associated adiposity, and GH-deficiency paradigms
La dosis del suplemento puede variar entre 3 mg y 2.000 mg al da
Steullet P, Neijt HC, Cunod M, Do KQ (2006)
(PDF) Santesso, D.L., Bogdan, R., Birk, J.L., Goetz, E.L., Holmes, A.J., Pizzagalli, D.A
First, oral and microdosed compounded preparations carry the same regulatory status as the injectables: not FDA-approved, and not FDA-reviewed before marketing